BSPK: Bespoke Extracts, Inc. Stock

by  •  • Comments Off on BSPK: Bespoke Extracts, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 0.61
Enterprise Value ($M) 1.51
Book Value ($M) -1.72
Book Value / Share -0.17
Price / Book -0.35
NCAV ($M) -2.00
NCAV / Share -0.20
Price / NCAV -0.31

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -3.10
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.06
Current Ratio 0.08

Balance Sheet (mrq) ($M)
Current Assets 0.08
Assets 0.35
Liabilities 2.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.79
Operating Income -1.47
Net Income -1.48
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -0.42
Cash from Investing 0.00
Cash from Financing 0.40

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2024-01-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023 ☐ TRANSITION REPORT PURSUAN
2023-09-28 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO
2023-07-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-15 122 3,122 3.91
2024-05-13 100 100 100.00

(click for more detail)

Similar Companies
BLPH – Bellerophon Therapeutics, Inc. BMMJ – Body and Mind Inc.
BQST – BioQuest Corp. BSPM – Biostar Pharmaceuticals, Inc.
BTAX – Biostax Corp.


Financial data and stock pages provided by
Fintel.io